Evidence map›Paper›PMID 39498045›Full record

ArticleHeliyon2024

Identifying at-risk patients for congenital heart disease using integrated predictive models and fuzzy clustering analysis: A cross-sectional study.

Amirreza Salehi, Majid Khedmati

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Amirreza SalehiDepartment of Industrial Engineering, Sharif University of Technology, Tehran, Iran.
Majid KhedmatiDepartment of Industrial Engineering, Sharif University of Technology, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Congenital heart disease (CHD) remains a significant global health concern, affecting approximately 1 % of newborns worldwide. While its accurate causes often remain elusive, a combination of genetic and environmental factors is implicated. In this cross-sectional study, we propose a comprehensive prediction framework leveraging Machine Learning (ML) and Multi-Attribute Decision Making (MADM) techniques to enhance CHD diagnostics and forecasting. Our framework integrates supervised and unsupervised learning methodologies to remove data noise and address imbalanced datasets effectively. Through the utilization of imbalance ensemble methods and clustering algorithms such as K-means, we enhance predictive accuracy, particularly in non-clinical datasets where imbalances are prevalent. Our results demonstrate an improvement of 8 % in recall compared to existing literature, showcasing the efficacy of our approach. Moreover, our framework identifies clusters of patients at the highest risk using MADM techniques, providing insights into susceptibility to CHD. Fuzzy clustering techniques further assess the degree of risk for individuals within each cluster, enabling personalized risk evaluation. Importantly, our analysis reveals that unhealthy lifestyle factors, annual per capita income, nutrition, and folic acid supplementation emerge as crucial predictors of CHD occurrences. Additionally, environmental risk factors and maternal illnesses significantly contribute to the predictive model. These findings underscore the multifactorial nature of CHD development, emphasizing the importance of considering socioeconomic and lifestyle factors alongside medical variables in CHD risk assessment and prevention strategies. Our proposed framework offers a promising avenue for early identification and intervention, potentially mitigating the burden of CHD on affected individuals and healthcare systems globally.

Indexed as

ClusteringCongenital heart diseaseMachine learningMulti-attribute decision-makingRisk assessment

Identifiers

PMID39498045
PMCPMC11532873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.